Welch Allyn Adds Masimo Corporation’s Masimo(R) Total Hemoglobin to Connex(R) Vital Signs Monitor

SKANEATELES FALLS, N.Y.--(BUSINESS WIRE)--Welch Allyn, a leading global manufacturer of frontline medical products and solutions, today announced it has added Masimo® continuous and noninvasive total hemoglobin (SpHb®) to its Connex® Vital Signs Monitor (CVSM). Made possible through a strategic partnership with Masimo Corporation (NASDAQ: MASI), the availability of SpHb on the CVSM multiparameter device enables healthcare professionals to obtain rapid and continuous hemoglobin measurements at the point-of-care without drawing blood. Instead, Masimo’s SpHb parameter—part of the Masimo rainbow® SET Pulse CO-Oximetry™ platform—uses advanced signal processing of multiple wavelengths of light obtained from noninvasive, easy-to-apply finger sensors.

MORE ON THIS TOPIC